Abstract:The word autophagy is derived from the Greek roots “auto”(self) and “phagy” (eating) and broadly refers to the cellular catabolic processes, in which cytoplasmic materials are transported to lysosomes for degradation. Generally, autophagy is divided into three categories: macroautophagy, microautophagy and chaperone-mediated autophagy (CMA). Started four decades ago, autophagy research has expanded from a relatively minor research area to one of the most exciting and important topic in cell biology. For example, the total number of autophagy papers published in peer review journals worldwide has been increased 15 fold in the past ten years, and many of them are present in the top journals such as Nature, Sciences and Cell. A first specific journal “Autophagy” emerged in 2002, has become one of the leading international journals in biology. Meanwhile, a number of autophagy-related genes and pathways have been identified and innovative tools for genetic manipulation and chemical compounds to target autophagy components and pathways have been developed1,2,3,4. Furthermore, a comprehensive methodology article “Guidelines for the use and interpretation of assays for monitoring autophagy” published in 2008 and revised in 2012 is very useful for investigators to conduct the research in the field of autophagy5,6. Moreover, databases that are specifically dedicated to autophagy can be found in the websites of Human Autophagy-dedicated Database (HADb; www.autophagy.lu) and the Autophagy Database (http://tp-apg.genes.nig.ac.jp/autophagy/). In order to develop new concepts and strategies for investigating the autophagy biology and function, and uncovering its relevance with diseases, autophagy research needs highly collaborative and interactive efforts between the different disciplines and specific areas. Important progress has been achieved in the recent years in defining the role of autophagy in human diseases such as cancers, cardiovascular diseases, metabolism disorders, immune-mediated diseases, and neurodegenerative diseases, etc. In addition, a number of new drugs in the clinical trials against cancers, immune diseases, and neurodegenerative diseases affect or act through autophagy. It is conceivable that exploring the molecular mechanisms of autophagy opens an avenue for development of novel drugs to treat these devastating diseases. In the recent years, Chinese researchers have contributed a great deal to autophagy research in the basic and clinical aspects7,8,9,10,11, and published numerous articles that account for 10% the total worldwide in this topic, and the percentage is steadily increasing. By the way, “Autophagy: biology and disease”, a monograph in Chinese, was published in 201112, and became one of the hot selling books in China in 2012. In order to give a broad picture on recent progress in autophagy research and help gain a deep insight into autophagy biology and the related disease, Acta Pharmacologica Sinica launched this special edition “Autophagy and Drug Discovery”. As the editors for this special edition, we invited several experts in China and abroad to contribute 13 articles, which covered the important aspects of basic and clinical research on autophagy and refleced the updated development in this field. Several major issues in autophagy research were highlighted in this special edition: 1. Autophagy regulates important biological functions, such as cell survival, cell death, cell metabolism, development, aging, infection and immunity. At a cellular level, the involvement of autophagy in the cell death and cell survival process appears to be complex. The multifunctional roles of autophagy are explained by its ability to interact with distinct key components in various cell pathways. 2. Autophagy has its own regulatory mechanisms, but this process is not isolated. Autophagy is coordinated with other cellular activities to maintain cell homeostasis. Owing to the dual roles of autophagy in cell death and the specificity of disease progression, the exact roles and underlying mechanisms of autophagy in various diseases are not fully understood. The application of autophagy inhibitors and activators will help us understand the regulation of autophagy in human diseases and provide insight into the development of autophagy-targeted drugs. 3. Although cells can manifest a clear increase in the numbers of autophagosomes shortly before or during their death, this phenomenon is sometimes due to defects in autophagosomal maturation and, hence, decreased, rather than increased, autophagy. For many diseases, the upregulation of autophagy is a promising therapeutic target. Combining the knowledge of autophagy compromise in neurodegenerative deseases with that of signaling pathways and drugs available to control autophagy may promote the development of optimal therapeutics. 4. Dysfunctional autophagy is found in ageing tissues and several ageing-associated diseases. The lifespan of model organisms such as yeast, worms, flies, and mice can be extended through promoting autophagy, either by genetic manipulations such as over-expression of Sirtuin 1, or by administrations of rapamycin, resveratrol or spermidine, supporting the notion that autophagy may play an important role in delaying ageing or extending lifespan. 5. Cells deploy two mechanisms for intracellular protein degradation: the ubiquitin-proteasome system and the autophagy-lysosome system. The UPS and autophagy have long been viewed as independent and parallel degradation systems with no point of intersection. Several lines of evidence have suggested that the UPS and autophagy are functionally interrelated catabolic processes. 6. Impaired autophagic flux has been linked to a variety of human pathophysiological process, including neurodegeneration, cancer, myopathy, cardiovascular and immune-mediated disorders. There is a growing need to identify and quantify the status of autophagic flux in different pathological conditions. Given that autophagy is a highly dynamic and complex process regulated at multiple steps, it is of importance to measure the rate of delivery of autophagy substrates to lysosomes or the vacuole, followed by degradation, rather than to assess the steady-state levels of autophagosomes in an isolated approach (eg, by counting GFP-LC3 puncta, monitoring the amount of LC3-II without examining turnover, or by single time point electron micrographs)6. It is strongly recommended to use multiple assays whenever possible, instead of relying on the results from a single method to assess autophagic flux. 7. Encouraging progress has been made in autophagy-based anticancer therapeutics, and some autophagy-modulating drugs such as rapamycin and tamoxifen have been approved for clinical use in cancer management, and thus convincing autophagy as a promising therapeutic target in cancer. More importantly, attractive strategies for the identification of autophagy-modulating agents are emerging, which may undoubtedly provide new clues for launching a new wave in anticancer drug discovery. A better understanding of potential molecular mechanisms implicated in autophagy and the intrinsic relationships between autophagy and cancers at the level of entire network will help achieve the ultimate goal of conquering cancers. Owing to the participation of more and more researchers from various fields and increasing funding opportunity, we will see continuous expansion and progress in autophagy research. It may be particularly interest to study the interactions of autophagy within the subgroup of autophagy family in mammals cells such as aggephagy, CMA, lippophagy, mitophagy, pexophagy, reticulophagy, ribophagy, xenophagy, and zymophagy/crinophagy1, to define the roles of other cellular activity in macromolecular degradation and cell metabolism; to study the underlying mechanisms of dual effects of autophagy on cell survival; to determine if selective manipulation of autophagy pathway could be a therapeutic strategy for cancers, metabolic disorders, immune diseases, and neurodegenerative disorders. We expect that a better understanding the roles and regulation of autophagy could bring us deeper insight into pathogenic mechanisms of many diseases and provide useful information leading to development of novel therapies.

Abstract:Autophagy is a lysosome-based degradation process whose primary function is to degrade long-lived proteins and recycle cellular components. So far, 3 types of autophagy have been documented, including macroautophagy, microautophagy and chaperone-mediated autophagy. Autophagy has been shown to degrade cargo in selective and no-selective manners. In literature, the term “autophagy” usually indicates macroautophagy. Macroautophagy is characterized by the formation of double membrane vesicles termed autophagosomes. The biogenesis of autophagosomes is a subject of intensive study in recent years. Autophagy can be induced by various stimuli, including nutrient starvation, hypoxia and various chemical reagents such as rapamycin. In yeast, the major physiological function of autophagy is to adjust the metabolic machinery in response to varying nutrient status, thereby ensuring the cell survival in an ever-changing environment. In mammalian cells, however, the roles of autophagy are more complex. Autophagy has been implicated in many different cellular processes as varied as cell survival, death, pathogen clearance, and antigen presentation. Various diseases have been linked to dysfunctioning autophagy. There are strong genetic and animal data supporting the direct connections between autophagy and cancers, neurodegenerative diseases, and chronic inflammation. Albeit the exact mechanisms of autophagy in each of the diseases remain to be determined, modulating autophagy has become a target for therapeutic approaches for various diseases. During the early days after its discovery in 1950s, autophagy had been considered as a relatively backwater field. Identification of genes regulating autophagy in 1990s opened up the field. In the past two decades, autophagy study has grown explosively. As a result, our understanding in every aspect of autophagy has been dramatically expanded. In this special issue, the history of autophagy study, the molecular machinery of autophagy, how nutrient signaling regulates autophagy, the biogenesis of autophagosome, the role of autophagy in various diseases, autophagy study in the model organism C. elegans, mitophagy, and chaperone-mediated autophagy (CMA) are reviewed and summarized by leading experts in the autophagy field. Shortly after the discovery of lysosomes by Christian de Duve in 1950s, autophagosome was observed using electron microscopy. In 1963, de Duve coined the term autophagy, which referred to the delivery of intracellular contents to lysosomes. In the next 30 years, although some progress had been made, autophagy largely remained to be an obscure field due to the lack of understanding at the molecular level. The turning point of autophagy research came at early 1990s when Yoshinori Ohsumi discovered that autophagy could also happen in yeast. This discovery led Ohsumi and other groups to discover a set of “ATG” genes, which opened the possibility to understand the molecular and cellular mechanisms of autophagy and to dissect the roles of autophagy in physiological and pathological settings. The leading piece of this special issue is a review about the historical landmarks of autophagy research, authored by Yoshinori Ohsumi. Dr Ohsumi summarizes the key discoveries of autophagy research, with an emphasis on the earlier phase of the field and a particular focus on studies carried out in yeast. Immediately after the identification of “ATG” genes, various groups started to dissect the roles of these ATG genes in autophagy. Tremendous progress has been made in the past two decades in terms of understanding the molecular mechanism of autophagy, the molecular machinery that governs various steps of autophagy, and the structures of some of the key molecules involved. Dr Klionsky and colleagues summarize these advances in their review article. Nutrient starvation is the most widely used and arguably the most physiologically relevant stimulus of autophagy. Cell senses nutrient starvation by nutrient-sensitive kinases such as mTORC1 and AMPK. Through these kinases, signaling is passed to the autophagy machinery by various autophagy-specific signaling complexes including the Atg1/ULK1 complex and Vps34 complex. Extensive crosstalk and feedback loops have been discovered recently, highlighting the complex and dynamic nature of the autophagy signaling pathway. In their review article, Dr Guan and colleagues summarize the current understanding of how nutrient signaling regulates autophagy. The biogenesis of autophagosomes involves sophisticated and extensive membrane reshuffling. Various intracellular membrane systems including the ER, Golgi, mitochondrion, plasma membrane, and endocytic vesicles have been implicated in autophagosome formation. Despite the complex nature of autophagosome biogenesis, an increasingly clear picture of autophagosome formation is emerging from recent progress in the field. Some of the long standing key questions on autophagosome formation, including the membrane source, and where and how autophagsosomes are made, have been addressed or at least partially addressed. These advances in our understanding of autophagosome formation are summarized in the review article by Drs Shibutani and Yoshimori. Although autophagy has been shown to play import roles in various physiological settings and autophagy-deficient animals develop phenotypes closely similar to human diseases, the direct link between dysfunction or mis-regulation of autophagy and human diseases has only been reported fairly recently. Various clinical trials of autophagy- modulating reagents have been carried out. The review by Drs Jiang and Mizushima summarizes the recent progress on this important front. Model organisms have been used extensively in autophagy study. Besides the yeast and mammalian systems, C. elegans has emerged as an important model system to study autophagy, especially for selective autophagy and the role of autophagy in developmental settings. The current knowledge of autophagy in C. elegans is summarized in the review by Drs Yang and Zhang. Besides macroautophagy, there are other types of autophagy. CMA is a pathway in which CMA substrate proteins are selectively targeted into lysosomes for degradation. CMA selectively degrades proteins in a timely fashion, thus playing important roles in regulating various physiological processes. Drs Cuervo and Wong summarize our current understanding of CMA. Cargos including organelles, protein aggregates, and intracellular pathogens can be recognized and engulfed by selective autophagy. Mitophagy, which degrades damaged mitochondria, is the most studied form of selective autophagy. A lot of progress has been made recently in understanding the molecular mechanism and physiological relevance of mitophagy, which is covered in a review by Dr Okamoto and colleagues in a later issue. So far, there are many well written reviews on the subject of autophagy. Nevertheless, due to the rapid progress of autophagy research, new discoveries need to be summarized and synthesized in a timely fashion. Therefore, a timely update about the latest discoveries is certainly useful for “insiders” of the autophagy field. On the other hand, more and more new researchers have been drawn into this fascinating field, and thus a collection of reviews which cover the major topics in autophagy are especially useful for those who have just joined the autophagy community. We hope that the collection of authoritative reviews in this special issue on autophagy will prove useful for all researchers in this fast growing field.

Autophagy in Its (Proper) Context: Molecular Basis, Biological Relevance, Pharmacological Modulation, and Lifestyle Medicine

Autophagy: A Key Regulator of Homeostasis and Disease: An Overview of Molecular Mechanisms and Modulators

Autophagy in healthy aging and disease

Autophagy in major human diseases

Targeting Autophagy to Overcome Human Diseases

New horizon in autophagy research

From defense to dysfunction: Autophagy's dual role in disease pathophysiology

Autophagy and Autophagy-Related Diseases: A Review

Autophagy Regulators As Potential Cancer Therapeutic Agents: A Review

Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies?

Targeting Autophagy in Obesity: from Pathophysiology to Management.

Targeting selective autophagy and beyond: From underlying mechanisms to potential therapies

Role of Autophagy and Its Significance in Cellular Homeostasis

Autophagy in aging-related diseases and cancer: Principles, regulatory mechanisms and therapeutic potential

Autophagy: cellular and molecular mechanisms

An Overview of Autophagy: Morphology, Mechanism, and Regulation

Autophagy: a necessary evil in cancer and inflammation

Recent progress in autophagy

Anatomy of autophagy: from the beginning to the end.

Mechanobiology of Autophagy: The Unexplored Side of Cancer

Autophagy Intertwines with Different Diseases—Recent Strategies for Therapeutic Approaches